Biogen
BIIB
110,71 €
Share price
-1.07%
Change (1 day)
-44.16%
Change (1 year)
Categories
Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
Number of shares outstanding for Biogen (BIIB)
Number of shares outstanding as of July 2025 : 146,100,000
According to Biogen's latest financial reports and stock price the company's current number of shares outstanding is 146,100,000. At the end of 2025 the company had 146,100,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Biogen from 2001 to 2025
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2025 | 0.14 B | 0.27% |
| 2024 | 0.14 B | 0.55% |
| 2023 | 0.14 B | 0.56% |
| 2022 | 0.14 B | -1.91% |
| 2021 | 0.14 B | -4.42% |
| 2020 | 0.15 B | -13.55% |
| 2019 | 0.17 B | -11.01% |
| 2018 | 0.19 B | -5.53% |
| 2017 | 0.21 B | -2.35% |
| 2016 | 0.21 B | -1.72% |
| 2015 | 0.22 B | -6.4% |
| 2014 | 0.23 B | -0.34% |
| 2013 | 0.23 B | -0.14% |
| 2012 | 0.23 B | -2.61% |
| 2011 | 0.24 B | 1.29% |
| 2010 | 0.23 B | -16.98% |
| 2009 | 0.28 B | -0.85% |
| 2008 | 0.29 B | 0.85% |
| 2007 | 0.28 B | -14.51% |
| 2006 | 0.33 B | 0.44% |
| 2005 | 0.33 B | 0.53% |
| 2004 | 0.33 B | 115.29% |
| 2003 | 0.15 B | 4% |
| 2002 | 0.14 B | 0.75% |
| 2001 | 0.14 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 538,000,000 | 268.24% | 🇺🇸 USA |
 Gilead Sciences GILD | 1,246,000,000 | 752.84% | 🇺🇸 USA |
 AbbVie ABBV | 1,768,000,000 | 1,110.13% | 🇺🇸 USA |
 Pfizer PFE | 5,675,000,000 | 3,784.33% | 🇺🇸 USA |
 Johnson & Johnson JNJ | 2,405,625,000 | 1,546.56% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | 1,242,000 | -99.15% | 🇺🇸 USA |
 Sanofi SNY | 2,467,800,000 | 1,589.12% | 🇫🇷 France |
 Bio-Rad Laboratories BIO | 27,941,000 | -80.88% | 🇺🇸 USA |
 Illumina ILMN | 159,000,000 | 8.83% | 🇺🇸 USA |
 Qiagen QGEN | 218,377,000 | 49.47% | 🇳🇱 Netherlands |